Medtronic MiniMed 670G insulin pump recalled for incorrect insulin delivery based on pump position
What this means
Medtronic MiniMed insulin pumps can deliver too much or too little insulin when the pump is positioned higher or lower than the infusion site on your body. This happens because gravity affects the pressure inside the pump tubing. Too much insulin can cause dangerously low blood sugar; too little can cause dangerously high blood sugar.
- Contact Medtronic immediately if you use a MiniMed 670G, 630G, Paradigm, or 600-series pump
- Keep your pump at approximately the same height as your infusion site (where the needle enters your skin)
- Monitor your blood sugar more frequently while using the pump
- Watch for signs of low blood sugar (shaking, sweating, confusion) or high blood sugar (thirst, frequent urination)
The agency's original wording
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1739-2026More Medtronic recalls
- FDA-Device2026-07-29Medtronic MiniMed Go App recalled for missed insulin alerts at night
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.